{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:26:54Z","timestamp":1788200814654,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.path.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T19:07:00Z","timestamp":1536001620000},"page":"589-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Updates in Cervical Cytology"],"prefix":"10.1016","volume":"11","author":[{"given":"Catherine J.","family":"Roe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina Z.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2018.05.001_bib1","unstructured":"National Cancer Institute. 2014. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html. Accessed May 12, 2017."},{"key":"10.1016\/j.path.2018.05.001_bib2","unstructured":"National Health Interview Survey, 2015. Public-use Data File and Documentation: National Center for Health Statistics, Centers for Disease Control and Prevention. 2016. Available at: http:\/\/www.cdc.gov\/nchs\/nhis\/. Accessed May 12, 2017."},{"key":"10.1016\/j.path.2018.05.001_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ypmed.2017.05.004","article-title":"National assessment of HPV and Pap tests: changes in cervical cancer screening, National Health Interview Survey","volume":"100","author":"Watson","year":"2017","journal-title":"Prev Med"},{"issue":"5","key":"10.1016\/j.path.2018.05.001_bib4","first-page":"671","article-title":"Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012","volume":"26","author":"Tangka","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.path.2018.05.001_bib5","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1089\/jwh.2006.0279","article-title":"Cervical cancer screening among foreign-born women by birthplace and duration in the United States","volume":"16","author":"Tsui","year":"2007","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.path.2018.05.001_bib6","series-title":"Healthy People 2020 [internet]","year":"2016"},{"issue":"4","key":"10.1016\/j.path.2018.05.001_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"Suppl 24","key":"10.1016\/j.path.2018.05.001_bib8","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1002\/cncr.30906","article-title":"Cervical cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study","volume":"123","author":"Benard","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.path.2018.05.001_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.59566\/IJBS.2013.9205","article-title":"A\u00a0comparison of 3 ways of conventional pap smear, liquid-based cytology and colposcopy vs cervical biopsy for early diagnosis of premalignant lesions or cervical cancer in women with abnormal conventional pap test","volume":"9","author":"Karimi-Zarchi","year":"2013","journal-title":"Int J Biomed Sci"},{"issue":"10","key":"10.1016\/j.path.2018.05.001_bib10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-155-10-201111150-00376","article-title":"Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force","volume":"155","author":"Whitlock","year":"2011","journal-title":"Ann Intern Med"},{"issue":"7609","key":"10.1016\/j.path.2018.05.001_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial","volume":"335","author":"Ronco","year":"2007","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.path.2018.05.001_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.path.2018.05.001_bib13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial","volume":"302","author":"Siebers","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.path.2018.05.001_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/dc.21199","article-title":"Comparison of the sensitivity of conventional cytology and the ThinPrep Imaging System for 1,083 biopsy confirmed high-grade squamous lesions","volume":"38","author":"Halford","year":"2010","journal-title":"Diagn Cytopathol"},{"issue":"8","key":"10.1016\/j.path.2018.05.001_bib15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.28514","article-title":"Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial","volume":"134","author":"Wright","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.path.2018.05.001_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-6413-4-6","article-title":"Introduction of the Thin Prep Imaging System (TIS): experience in a high volume academic practice","volume":"4","author":"Chivukula","year":"2007","journal-title":"CytoJournal"},{"issue":"5","key":"10.1016\/j.path.2018.05.001_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1159\/000326001","article-title":"Implementation and evaluation of a new automated interactive image analysis system","volume":"50","author":"Bolger","year":"2006","journal-title":"Acta Cytol"},{"issue":"9","key":"10.1016\/j.path.2018.05.001_bib18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/dc.20689","article-title":"Cervical cytology reading times: a comparison between ThinPrep Imager and conventional methods","volume":"35","author":"Davey","year":"2007","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.001_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2006.07.025","article-title":"Comparison of computer-assisted and manual screening of cervical cytology","volume":"104","author":"Lozano","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.path.2018.05.001_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/PAP.0b013e31828d1893","article-title":"Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening","volume":"20","author":"Laudadio","year":"2013","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.path.2018.05.001_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.23366","article-title":"Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions","volume":"114","author":"Yoshida","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2018.05.001_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncy.20061","article-title":"Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens","volume":"118","author":"Yu","year":"2010","journal-title":"Cancer Cytopathol"},{"issue":"9","key":"10.1016\/j.path.2018.05.001_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/dc.22944","article-title":"Performance of ProEx C and PreTect HPV-Proofer E6\/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology","volume":"41","author":"Alaghehbandan","year":"2013","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.001_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000332978","article-title":"p16(INK4a) and ProEx C immunostains facilitate differential diagnosis of hyperchromatic crowded groups in liquid-based Papanicolaou tests with menstrual contamination","volume":"56","author":"Ge","year":"2012","journal-title":"Acta Cytol"},{"issue":"2","key":"10.1016\/j.path.2018.05.001_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000335065","article-title":"Immunomarkers in gynecologic cytology: the search for the ideal 'biomolecular Papanicolaou test'","volume":"56","author":"Pinto","year":"2012","journal-title":"Acta Cytol"},{"issue":"5","key":"10.1016\/j.path.2018.05.001_bib26","first-page":"241","article-title":"Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild\/moderate dysplasia","volume":"26","author":"Griesser","year":"2004","journal-title":"Anal Quant Cytol Histol"},{"issue":"3","key":"10.1016\/j.path.2018.05.001_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5858\/134.3.331","article-title":"Practices of participants in the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology, 2006","volume":"134","author":"Eversole","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.path.2018.05.001_bib28","doi-asserted-by":"crossref","first-page":"184.e1-11","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.path.2018.05.001_bib29","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"issue":"4\u20135","key":"10.1016\/j.path.2018.05.001_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000477556","article-title":"The Bethesda System for reporting cervical cytology: a historical perspective","volume":"61","author":"Nayar","year":"2017","journal-title":"Acta Cytol"},{"issue":"16","key":"10.1016\/j.path.2018.05.001_bib31","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.path.2018.05.001_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncy.21521","article-title":"The Pap test and Bethesda 2014","volume":"123","author":"Nayar","year":"2015","journal-title":"Cancer Cytopathol"},{"issue":"19","key":"10.1016\/j.path.2018.05.001_bib33","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kjaer","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.path.2018.05.001_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.path.2018.05.001_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1309\/AJCPHVD7MIP3FYVV","article-title":"Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study","volume":"144","author":"Reid","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.path.2018.05.001_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/his.12012","article-title":"New developments in endocervical glandular lesions","volume":"62","author":"McCluggage","year":"2013","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.path.2018.05.001_bib37","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1002\/ijc.30032","article-title":"Evaluating HPV-negative CIN2+ in the ATHENA trial","volume":"138","author":"Petry","year":"2016","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.path.2018.05.001_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ygyno.2015.01.551","article-title":"Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial","volume":"137","author":"Monsonego","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.path.2018.05.001_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/LGT.0b013e3182a577c7","article-title":"Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction","volume":"18","author":"Hopenhayn","year":"2014","journal-title":"J\u00a0Low Genit Tract Dis"},{"issue":"11","key":"10.1016\/j.path.2018.05.001_bib40","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5858\/2004-128-1224-BIARRP","article-title":"Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology","volume":"128","author":"Davey","year":"2004","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.path.2018.05.001_bib41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/GCO.0000000000000208","article-title":"Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination","volume":"27","author":"Lehtinen","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.path.2018.05.001_bib42","first-page":"36","article-title":"Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study","volume":"36","author":"Fisher","year":"2014","journal-title":"J\u00a0Public Health (Oxf)"},{"key":"10.1016\/j.path.2018.05.001_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.acc.2017.01.004","article-title":"Human papillomavirus and its testing assays, cervical cancer screening, and vaccination","volume":"81","author":"Zhu","year":"2017","journal-title":"Adv Clin Chem"},{"issue":"2","key":"10.1016\/j.path.2018.05.001_bib44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2009.04.005","article-title":"The impact of human papillomavirus vaccination on cervical cancer prevention efforts","volume":"114","author":"Massad","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:41:05Z","timestamp":1761748865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918118300333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1875918118300333"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2018.05.001","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in Cervical Cytology","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}